Publications from completed UCARE scientific projects can be found here.

PREG-CU

Effects of pregnancy on chronic urticaria: Results of the PREG-CU UCARE study.

Kocatürk E, Al-Ahmad M, Krause K, Gimenez-Arnau AM, Thomsen SF, Conlon N, Marsland A, Savk E, Criado RF, Danilycheva I, Fomina D, Godse K, Khoshkhui M, Gelincik A, Degirmentepe EN, Demir S, Ensina LF, Kasperska-Zajac A, Rudenko M, Valle S, Medina I, Bauer A, Zhao Z, Staubach P, Bouillet L, Küçük ÖS, Ateş C, Maurer M. Allergy. 2021 Oct;76(10):3133-3144. doi: 10.1111/all.14950. Epub 2021 Jun 12. PMID: 34022061.

Treatment patterns and outcomes in patients with chronic urticaria during pregnancy: Results of PREG-CU, a UCARE study.

Kocatürk E, Al-Ahmad M, Krause K, Gimenez-Arnau AM, Thomsen SF, Conlon N, Marsland A, Savk E, Criado RF, Danilycheva I, Fomina D, Godse K, Khoshkhui M, Gelincik A, Degirmentepe EN, Demir S, Ensina LF, Kasperska-Zajac A, Rudenko M, Valle S, Medina I, Bauer A, Zhao Z, Staubach P, Bouillet L, Küçük ÖS, Baygül A, Maurer M. J Eur Acad Dermatol Venereol. 2022 Sep 6. doi: 10.1111/jdv.18574. Online ahead of print.

Total IgE levels are linked to the course of chronic spontaneous urticaria during pregnancy.

Kocatürk E, Thomsen SF, Al-Ahmad M, Gimenez Arnau AM, Conlon N, Şavk E, Criado RFJ, Danilycheva I, Fomina D, Khoshkhui M, Gelincik A, Yüksel EN, Ertan S, Ensina LF, Kasperska-Zajac A, Rudenko M, Bauer A, Medina IV, Maurer M. J Allergy Clin Immunol Pract. 2022 Oct 26:S2213-2198(22)01061-3. doi: 10.1016/j.jaip.2022.10.018. Online ahead of print.

COLD-CE

Risk factors for systemic reactions in typical cold urticaria: Results from the COLD-CE study.

Bizjak M, Košnik M, Dinevski D, Thomsen SF, et. al. Allergy. 2021 Dec 4. doi: 10.1111/all.15194. Epub ahead of print.

Adrenaline autoinjector is underprescribed in typical cold urticaria patients.

Bizjak M, Košnik M, Dinevski D, Thomsen SF, et al. Allergy. 2022 Jul;77(7):2224-2229. doi: 10.1111/all.15274. Epub 2022 Mar 14. PMID: 35258111.

CURICT

Chronic urticaria patients are interested in apps to monitor their disease activity and control: A UCARE CURICT analysis.

Cherrez-Ojeda I, Vanegas E, Cherrez A, Felix M, Weller K, Magerl M, Maurer RR, Mata VL, Kasperska-Zajac A, Sikora A, Fomina D, Kovalkova E, Godse K, Rao ND, Khoshkhui M, Rastgoo S, Criado RFJ, Abuzakouk M, Grandon D, Van Doorn MBA, Rodrigues Valle SO, De Souza Lima EM, Thomsen SF, Ramón GD, Matos Benavides EE, Bauer A, Giménez-Arnau AM, Kocatürk E, Guillet C, Larco JI, Zhao ZT, Makris M, Ritchie C, Xepapadaki P, Ensina LF, Cherrez S, Maurer M. Clin Transl Allergy. 2021 Dec;11(10):e12089. doi: 10.1002/clt2.12089. PMID: 34962721; PMCID: PMC8684305.

The usage, quality and relevance of information and communications technologies in patients with chronic urticaria: A UCARE study.

Maurer M, Weller K, Magerl M, et. al. World Allergy Organ J. 2020 Oct 30;13(11):100475. doi: 10.1016/j.waojou.2020.100475. PMID: 33204387; PMCID: PMC7606865.

How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE study.

Cherrez-Ojeda I, Vanegas E, Cherrez A, Felix M, Weller K, Magerl M, Maurer RR, Mata VL, Kasperska-Zajac A, Sikora A, Fomina D, Kovalkova E, Godse K, Rao ND, Khoshkhui M, Rastgoo S, Criado RF, Abuzakouk M, Grandon D, Van Doorn MBA, Oliveira Rodrigues Valle S, De Souza Lima EM, Thomsen SF, Ramón GD, Matos Benavides EE, Bauer A, Giménez-Arnau AM, Kocatürk E, Guillet C, Larco JI, Zhao ZT, Makris M, Ritchie C, Xepapadaki P, Ensina LF, Cherrez S, Maurer M. World Allergy Organ J. 2021 Jun 4;14(6):100542. doi: 10.1016/j.waojou.2021.100542. PMID: 34141048; PMCID: PMC8190491.

Synopsis CURICT

 

 

COVAC-CU

Chronic urticaria and COVID-19 vaccination: Qatar data (preliminary report of COVAC-CU-international).

Purayil S, Thalappil S, Al-Nesf M, Kocaturk E.. Qatar Med J. 2022 Apr 4;2022(2):2. doi: 10.5339/qmj.2022.fqac.2. PMID: 35968517; PMCID: PMC9340567.

Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study.

Kocatürk, E., Salameh, P., Sarac, E. et. al: The Journal of Allergy and Clinical Immunology. Published:August 11, 2023DOI:https://doi.org/10.1016/j.jaci.2023.07.019

DAEF-CIndUS

Eating Increases and Exercise Decreases Disease Activity in Patients With Symptomatic Dermographism.

Ertaş, R., Türk, M., Yücel, M. B., Muñoz, M., Ertaş, Ş. Atasoy, M., Maurer, M. JACI In Practoce, December 16, 2022DOI:https://doi.org/10.1016/j.jaip.2022.11.041

UVERSICU

Urticarial Vasculitis Differs From Chronic Spontaneous Urticaria in Time to Diagnosis, Clinical Presentation, and Need for Anti-Inflammatory Treatment: An International Prospective UCARE Study.

Bonnekoh H, Jelden-Thurm J, Allenova A, Chen Y, Cherrez-Ojeda I, Danilycheva I, Dorofeeva I, Jardim Criado RF, Criado PR, Gelincik Akkor A, Hawro T, Kocatürk E, Khoshkhui M, Metz M, Nasr I, Steć M, Zhao Z, Aulenbacher F, Salameh P, Altrichter S, Gonçalo M, Gimenez-Arnau A, Maurer M, Krause K, Kolkhir P. J Allergy Clin Immunol Pract. 2023 Sep;11(9):2900-2910.e21. doi: 10.1016/j.jaip.2023.06.030. Epub 2023 Jun 24. PMID: 37364667.

S-DOWN CSU

A global perspective on stepping down chronic spontaneous urticaria treatment: Results of the Urticaria Centers of Reference and Excellence SDown-CSU study.

Türk M, Kocatürk E, Ertaş R, Ensina L, Ferrucci S, Grattan C, Vestergaard C, Zuberbier Maurer M, Giménez‐Arnau A. Clinical and tranlsational Allergy. 14 February 2024 https://doi.org/10.1002/clt2.12343.

PROMUSE

Usage prevalence of angioedema patient-reported outcome measures: results from the UCARE and ACARE PROMUSE study.

Cherrez-Ojeda, Ivan et.al.

PMID: 38734372 No abstract available.

Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Urticaria Are Underused in Clinical Practice

Cherrez-Ojeda, Ivan et al.

The Journal of Allergy and Clinical Immunology: In Practice, Volume 12, Issue 6, 1575 – 1583.e1

Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Urticaria Are Underused in Clinical Practice.

Cherrez-Ojeda I, Bousquet J, Giménez-Arnau A, Godse K, Krasowska D, Bartosińska J, Szczepanik-Kułak P, Wawrzycki B, Kolkhir P, Allenova A, Allenova A, Tkachenko S, Teovska Mitrevska N, Mijakoski D, Stoleski S, Kolacinska-Flont M, Kuprys-Lipinska I, Molinska J, Kasperska-Zając A, Zajac M, Zamlynski M, Mihaltan F, Ulmeanu R, Zalewska-Janowska A, Tomaszewska K, Al-Ahmad M, Al-Nesf MA, Ibrahim T, Aqel S, Pesqué D, Rodríguez-González M, Wakida-Kuzunoki GH, Ramon G, Ramon G, Neisinger S, Bonnekoh H, Rukhadze M, Khoshkhui M, Fomina D, Larenas-Linnemann D, Košnik M, Oztas Kara R, Caballero López CG, Liu Q, Ivancevich JC, Ensina LF, Rosario N, Kvedariene V, Ben-Shoshan M, Criado RFJ, Bauer A, Cherrez A, Chong-Neto H, Rojo-Gutierrez MI, Rudenko M, Larco Sousa JI, Lesiak A, Matos E, Muñoz N, Tinoco I, Moreno J, Crespo Shijin C, Hinostroza Logroño R, Sagñay J, Faytong-Haro M, Robles-Velasco K, Zuberbier T, Maurer M.

J Allergy Clin Immunol Pract. 2024 Jun;12(6):1575-1583.e1. doi: 10.1016/j.jaip.2024.03.050. Epub 2024 Apr 9.

PMID: 38604531

DRUSO-CU

Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real-world data from a large multi-national UCARE study

Soegiharto R, Alizadeh Aghdam M, Sørensen JA, van Lindonk E, Bulut Demir F, Mohammad Porras N, Matsuo Y, Kiefer L, Knulst AC, Maurer M, Ritchie C, Rudenko M, Kocatürk E, Criado RFJ, Gregoriou S, Bobylev T, Kleinheinz A, Takahagi S, Hide M, Giménez-Arnau AM, Salman A, Kara RO, Dikicier BS, van Doorn MBA, Thomsen SF, van den Reek JMPA, Röckmann H. Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real-world data from a large multi-national UCARE study.
Allergy. 2024 Oct 8. doi: 10.1111/all.16334. Epub ahead of print. PMID: 39377745.

CRUSE

Validity, reliability and responsiveness of digital visual analogue scales for chronic spontaneous urticaria monitoring: A CRUSE® mobile health study

Sousa-Pinto B, Ramanauskaite A, Neisinger S, Witte-Händel E, Gimenez-Arnau AM, Guillet C, Parisi CAS, Katelaris CH, Fomina D, Larenas-Linnemann D, García E, Kocatürk E, Siebenhaar F, Lima H, Kaidashev I, Nasr I, Canales IO, Ojeda IC, Hébert J, Bousquet J, Bernstein JA, Peter J, Sanchez J, Sousa JIL, Kulthanan K, Weller K, Godse K, Rutkowski K, Lapina L, Bouillet L, Han LL, Ensina LF, Gonçalo M, Magerl M, van Doorn M, Metz M, Khoshkhui M, Hide M, Türk M, Kurjāne N, Conlon N, Salameh P, Kolkhir P, Asero R, Stepanenko R, Altrichter S, Gil-Mata S, Thomsen SF, Zuberbier T, Tsaryk V, Ye YM, Brzoza Z, Zhao Z, Maurer M. Validity, reliability and responsiveness of digital visual analogue scales for chronic spontaneous urticaria monitoring: A CRUSE® mobile health study. Allergy. 2025 Mar;80(3):750-761. doi: 10.1111/all.16371. Epub 2024 Oct 24. PMID: 39445583.

CRUSE® -An innovative mobile application for patient monitoring and management in chronic spontaneous urticaria

Neisinger S, Sousa Pinto B, Ramanauskaite A, Bousquet J, Weller K, Metz M, Magerl M, Kocatürk E, Cherrez-Ojeda I, Gimenez-Arnau AM, Parisi CAS, Altrichter S, Ensina LF, Bouillet L, Asero R, Gonçalo M, Guillet C, Rutkowski K, Bernstein JA, Hardin H, Godse K, Brzoza Z, Sousa JIL, Thomsen SF, van Doorn M, Hide M, Ye YM, Vandersee S, Lapiņa L, Peter J, Zhao Z, Han L, Nasr I, Rockmann-Helmbach H, Sørensen JA, Kara RÖ, Kurjāne N, Kurchenko AI, Kaidashev I, Tsaryk V, Stepanenko R, Maurer M. CRUSE® -An innovative mobile application for patient monitoring and management in chronic spontaneous urticaria. Clin Transl Allergy. 2024 Jan;14(1):e12328. doi: 10.1002/clt2.12328. PMID: 38282190; PMCID: PMC10764293.

CRUSE – What the first 100 days have taught us

Neisinger S, Pinto BS, Ramanauskaite A, Bousquet J, Weller K, Metz M, Magerl M, Kocatürk E, Ojeda IC, Gimenez-Arnau AM, Maurer M. CRUSE – What the first 100 days have taught us. Qatar Med J. 2023 Nov 19;2023(2):14. doi: 10.5339/qmj.2023.sqac.14. PMID: 38025340; PMCID: PMC10660846.

CURE

Comorbid Inducible Urticaria Is Linked to Non-Autoimmune Chronic Spontaneous Urticaria: CURE Insights

Kovalkova E, Fomina D, Borzova E, Maltseva N, Chernov A, Serdoteckova S, Weller K, Maurer M. Comorbid Inducible Urticaria Is Linked to Non-Autoimmune Chronic Spontaneous Urticaria: CURE Insights. J Allergy Clin Immunol Pract. 2024 Feb;12(2):482-490.e1. doi: 10.1016/j.jaip.2023.11.029. Epub 2023 Nov 24. PMID: 38008357.

Patients With Chronic Spontaneous Urticaria Who Have Wheals, Angioedema, or Both, Differ Demographically, Clinically, and in Response to Treatment-Results From CURE

Buttgereit T, Vera C, Aulenbacher F, Church MK, Hawro T, Asero R, Bauer A, Bizjak M, Bouillet L, Dissemond J, Fomina D, Giménez-Arnau AM, Grattan C, Gregoriou S, Kulthanan K, Kasperska-Zajac A, Kocatürk E, Makris M, Kolkhir P, Weller K, Magerl M, Maurer M. Patients With Chronic Spontaneous Urticaria Who Have Wheals, Angioedema, or Both, Differ Demographically, Clinically, and in Response to Treatment-Results From CURE. J Allergy Clin Immunol Pract. 2023 Nov;11(11):3515-3525.e4. doi: 10.1016/j.jaip.2023.08.020. Epub 2023 Aug 19. PMID: 37604426.

The Benefit of Complete Response to Treatment in Patients With Chronic Spontaneous Urticaria-CURE Results

Kolkhir P, Laires PA, Salameh P, Asero R, Bizjak M, Košnik M, Dissemond J, van Doorn M, Hawro T, Kasperska-Zajac A, Zajac M, Kocatürk E, Peter J, Parisi CAS, Ritchie CA, Kulthanan K, Tuchinda P, Fomina D, Kovalkova E, Khoshkhui M, Kouzegaran S, Papapostolou N, Du-Thanh A, Kamegashira A, Meshkova R, Vitchuk A, Bauer A, Grattan C, Staubach P, Bouillet L, Giménez-Arnau AM, Maurer M, Weller K. The Benefit of Complete Response to Treatment in Patients With Chronic Spontaneous Urticaria-CURE Results. J Allergy Clin Immunol Pract. 2023 Feb;11(2):610-620.e5. doi: 10.1016/j.jaip.2022.11.016. Epub 2022 Dec 5. PMID: 36481420.

Other Publications

Handbook of Urticaria

Kiran Godse, Abhishek De, Anant Patil

Publisher: Jaypee Brothers Medical Publishers (P) LtdEditor: ISBN: 978-93-5465-026-0

Management of urticarial vasculitis: A worldwide physician perspective.

Kolkhir P, Bonnekoh H, Kocatürk E, Hide M, Metz M, Sánchez-Borges M, Krause K, Maurer M.

World Allergy Organ J. 2020 Mar 5;13(3):100107. doi: 10.1016/j.waojou.2020.100107. eCollection 2020 Mar.PMID: 32180892

Clinical experience of a specialized urticaria outpatient clinic from a Portuguese UCARE.

Esteves Caldeira L, Paulino M, Coutinho C, Neto M, Pereira Barbosa M, Costa C.

Eur Ann Allergy Clin Immunol. 2021 May 5. doi: 10.23822/EurAnnACI.1764-1489.209. Online ahead of print. PMID: 33949172

TempTest®: un instrumento de precisión en las urticarias físicas.

Rodrigues-Valle S, Azizi G, Duarte-Dortas S Jr.

Rev Alerg Mex. 2021 Jan-Mar;68(1):2-6. doi: 10.29262/ram.v68i1.827. PMID: 34148323 Spanish.

Expert consensus on practical aspects in the treatment of chronic urticaria.

Bauer A, Dickel H, Jakob T, Kleinheinz A, Lippert U, Metz M, Schliemann S, Schwichtenberg U, Staubach P, Valesky E, Wagner N, Wedi B, Maurer M.

Allergo J Int. 2021;30(2):64-75. doi: 10.1007/s40629-021-00162-w. Epub 2021 Feb 24.

PMID: 33643777 Free PMC article. Review.

Effectiveness of Omalizumab in Patients with Chronic Inducible Urticaria: real-life experience from two UCARE centres.

Can PK, Salman A, Hoşgören-Tekin S, Kocatürk E.

J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e679-e682. doi: 10.1111/jdv.17385. Epub 2021 Jun 12.

PMID: 34013560 No abstract available.